專欄詠竹坊

WuXi group wrestles with uncertainty over pharma tariffs
藥明合聯再遭股東減持 ADC外包龍頭受關稅拖累?

Drugs services giant WuXi AppTec cashed in a stake in a sister firm to soften the blow from a first round of Trump tariffs, as the pharma sector braces for another barrage.
藥明康德資金流十分充裕,此次減持更像是財務投資的高位套現以及對關稅風險的提前規避。

This article only represents the author's own views.

(作者莫莉,本文僅代表作者個人觀點)

您已閱讀1%(70字),剩餘99%(7871字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。

詠竹坊

詠竹坊(官網鏈接)提供在香港和美國上市的中國企業相關新聞,重點關注中小企業和籌備上市的公司。

Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.

相關文章

相關話題

設置字型大小×
最小
較小
默認
較大
最大
分享×